How to Check for Muscle Loss While on Wegovy: A Complete Monitoring Guide for 2026

The Scale Says You're Winning—But Are Your Muscles?

Say you've lost a noticeable amount of weight in your first few months on Wegovy. Your clothes fit better and your blood sugar looks good. But the scale can't tell you what kind of tissue you lost. In the STEP 1 trial's DXA substudy, lean mass accounted for roughly 39% of the weight lost with semaglutide, and a 2024 review of GLP-1-based therapies found the reported share ranging from about 15% to more than 40% across studies.

Lean mass isn't the same as muscle—it also includes organs, water and bone—and imaging studies suggest much of the change may be an adaptive response to carrying less weight. Still, for older adults or anyone starting with low muscle, losing strength matters. This guide isn't meant to scare you off these medications; it's a practical way to notice changes early.

Why Muscle Loss During GLP-1 Therapy Deserves Your Attention

When you lose weight, your body doesn't lose fat alone; some lean tissue goes too. GLP-1 medications like Wegovy and Ozempic suppress appetite so effectively that many people end up eating far less than before—often including less protein.

That's great for shedding fat. Less great for maintaining the muscle tissue that keeps your metabolism humming, your bones protected, and your body functional as you age.

Who is most at risk? Researchers point to older age, low muscle mass before treatment, low protein intake and inactivity. In a trial of older adults with obesity on a weight-loss diet, lean mass fell about 5% with aerobic exercise alone versus 2-3% when resistance training was included. Many people don't notice a decline until everyday tasks—opening jars, climbing stairs—start to feel harder.

The At-Home Tests You Can Do This Week

You don't need fancy equipment to start monitoring your muscle health. These three checks take less than ten minutes combined and give you meaningful baseline data.

The Grip Strength Test

Buy a hand dynamometer—basic models are relatively inexpensive. Squeeze with your dominant hand three times, rest 30 seconds between attempts, and record your highest number. Under the European EWGSOP2 criteria, below 16 kg for women or 27 kg for men indicates low strength; the Asian AWGS 2019 criteria use 18 kg and 28 kg. Grip strength matters beyond muscle: in the large PURE study, lower grip strength was linked to higher cardiovascular and all-cause mortality. Test monthly and track the trend, and mention a steady decline to your doctor.

The Chair Stand Test

Sit in a standard dining chair with your arms crossed over your chest. Stand up and sit back down five times as fast as you can. Time yourself. EWGSOP2 treats more than 15 seconds as a sign of low strength, while AWGS 2019 uses 12 seconds or more. This test catches functional decline that grip strength alone might miss.

The Calf Circumference Check

Wrap a measuring tape around the widest part of your calf. The AWGS 2019 case-finding cutoffs are below 34 cm for men and below 33 cm for women. Swelling can skew the reading, so measure at the same time of day. It's not definitive on its own, but combined with other markers, it paints a clearer picture.

When to Ask for a Deeper Look: The DEXA Decision

At-home tests are your first line of defense. But there are specific situations where you should push for a more thorough evaluation, particularly a DEXA scan that measures body composition.

If you're at higher risk—older, already low in muscle, or losing weight quickly—ask your clinician whether a baseline body composition scan makes sense, either before starting or early in treatment. Repeating it after several months shows whether lean mass is changing faster than expected.

There's no formal guideline yet on muscle monitoring during GLP-1 therapy, but muscle researchers writing in The Lancet Diabetes & Endocrinology in 2024 argued that muscle mass and function should be assessed during medically induced weight loss. Practical triggers for a professional evaluation include grip strength or chair-stand results beyond the cutoffs above, very rapid weight loss, age over 65, or functional changes such as difficulty with stairs or carrying groceries.

Costs and insurance coverage for DEXA vary widely by country and facility. Your scan can report appendicular lean mass relative to height squared (ALM/height², sometimes called ALMI). Under EWGSOP2, values below 7.0 kg/m² for men or 5.5 kg/m² for women indicate low muscle quantity; sarcopenia is confirmed when this is combined with low strength.

The Action Thresholds: When Numbers Become Decisions

Knowing your numbers means little without knowing what to do with them. The zones below are practical self-monitoring heuristics built around the published cutoffs—not validated clinical thresholds—so use them to decide when to adjust your habits or talk to your doctor.

Green Zone (Keep Doing What You're Doing)

• Grip strength stable or improving and above the cutoffs
• Chair stand comfortably under 12 seconds
• ALM/height² comfortably above the cutoffs
• Weight loss steady rather than very rapid

Yellow Zone (Time to Adjust)

• Grip strength trending down from your baseline
• Chair stand approaching 12-15 seconds
• ALM/height² close to the cutoffs
• Add resistance training if you're not already doing it and review your protein intake

Red Zone (Talk to Your Doctor)

• Grip strength below the cutoffs or falling steadily
• Chair stand over 15 seconds
• ALM/height² below the cutoffs
• Discuss your treatment plan with your prescribing physician, work with a registered dietitian on protein, and consider a supervised resistance training program

Building Your Protection Plan: The 30-60-90 Framework

Muscle preservation during GLP-1 therapy works best as a three-layer system. Each layer adds protection.

The 30-Day Layer: Protein Optimization

Many people on GLP-1 medications don't eat enough protein, because protein-rich foods often feel least appealing when appetite is suppressed. The PROT-AGE expert group recommends 1.0-1.2 g of protein per kilogram of body weight daily for older adults, and an exploratory study in older adults with obesity found that more than 1.2 g/kg during weight loss was linked to better muscle retention. For a 70 kg person, 1.0-1.2 g/kg is 70-84 grams daily. Ask your clinician what target fits you, especially if you have kidney disease.

Spread it across meals. Front-load breakfast with 25-30 grams. Greek yogurt, eggs, cottage cheese. Make protein the non-negotiable part of every eating occasion, even when nothing sounds good.

The 60-Day Layer: Resistance Training

Resistance training matters most. In a randomized trial of older adults with obesity on a weight-loss program, lean mass fell by about 2-3% in the groups that did resistance training (alone or combined with aerobic exercise) versus about 5% with aerobic exercise alone, and strength rose about 18-19% versus 4%. Not cardio alone—resistance training specifically. Weights, bands, bodyweight exercises that challenge your muscles.

You don't need a gym membership. Squats, lunges, push-ups, rows with a resistance band. Two sessions weekly, 30 minutes each. Progressive overload matters: gradually increase difficulty over time.

The 90-Day Layer: Working With Your Healthcare Team

Schedule a dedicated conversation with your prescribing physician about muscle monitoring. Bring your at-home test results. Ask specifically about body composition evaluation options. Some clinics now offer bioelectrical impedance analysis (BIA) as a more accessible alternative to DEXA, though it's less precise.

In their 2024 commentary in The Lancet Diabetes & Endocrinology, muscle researchers called for assessing muscle mass and function during medically induced weight loss. If your care team isn't discussing it, it's reasonable to raise it yourself.

Special Considerations for Different Groups

Not everyone faces the same risk profile. Your monitoring intensity should match your vulnerability.

Adults Over 60

Age-related muscle loss (sarcopenia) was already happening before you started GLP-1 therapy. The medication accelerates an existing process. Monthly at-home testing isn't optional—it's essential. Consider quarterly professional evaluations rather than every six months.

People With Diabetes

Insulin resistance may make lean mass harder to keep: in a 2024 study in Obesity, people with lower insulin sensitivity before a diet lost more lean mass during weight loss. If you're taking Wegovy or Ozempic for type 2 diabetes, prioritise protein and resistance training, and ask your clinician about your individual protein target.

Those With Previous Significant Weight Loss

If you've lost substantial weight before—through surgery, other medications, or intensive dieting—your baseline muscle mass may already be compromised. Establish your starting point carefully and monitor aggressively.

The Practical Weekly Checklist

Here's what muscle preservation actually looks like in daily life during GLP-1 therapy:

Daily

• Track protein intake (aim for your target grams)
• Note any functional changes: stairs feeling harder, grip feeling weaker, unusual fatigue

Weekly

• Perform at least two resistance training sessions
• Weigh yourself once (same time, same conditions)

Monthly

• Complete grip strength test
• Perform chair stand test
• Measure calf circumference
• Review trends in your tracking data

Every 3-6 Months

• Body composition evaluation (DEXA or BIA)
• Dedicated conversation with healthcare provider about lean mass trends

What the Research Actually Shows About Recovery

What happens after stopping? In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year. Body composition during regain wasn't the focus of that study, so there's no reliable figure for how much lean mass returns. What is clear is that strength responds to training at any age.

The key word is "maintained." The protective habits you build during treatment become even more important if you eventually discontinue medication. Think of muscle preservation not as a temporary project but as a permanent lifestyle upgrade.

Reading Your Body's Signals

Numbers matter, but so does paying attention to how you feel. Your body sends signals about muscle loss before tests catch it.

Watch for: needing to use your arms to push yourself up from a chair, feeling unstable on uneven surfaces, noticing your rings fit looser but your pants fit the same, experiencing unusual fatigue after activities that used to feel easy, finding that you're cold more often than before.

These subjective experiences, combined with objective measurements, give you the full picture. Don't dismiss functional changes as "just getting older" or "normal weight loss stuff." They're data points worth tracking.

The goal isn't to avoid GLP-1 medications or to create anxiety about their effects. It's to use them intelligently, with eyes open to both their benefits and their potential costs. Muscle mass is precious. It's worth protecting.